Sirolimus CAS No: 53123-88-9 First discovered in 1972 and approved by the FDA in 1999, sirolimus can be used for a variety of disorders and medical events, including organ transplant procedures, lung disease, and heart protection. By suppressing the immune system, patients who have recently received a new organ have a better chance of their body accepting[…]
Sirolimus Provides Protection for the Heart, Kidneys, and Lungs
Immunosuppressant Tags: Sirolimus Dec 05, 2018
Sirolimus Continues to be Effective, Even When Thought to be Contraindicated
Drug Research & Development API, Immunosuppressant, Patent Expiration 2012, Patent Expiration 2013 Tags: hypertensionImmunosuppressantPfizerSirolimus May 21, 2012
As an immunosuppressant drug used to prevent transplant rejection, Sirolimus, CAS number 53123-88-9, is a macrolide. Particularly useful for kidney transplant patients, sirolimus is also known as the brand name Rapamune, which is marketed by Pfizer. The first patent for Rapamune is set to expire in October 2012. An addtional patent will expire in July[…]
Tacrolimus is a Reliable Treatment for Post Organ Transplant Recipients
Bulk Active Ingredient, Drug Research & Development API, Immunosuppressant Tags: ImmunosuppressantSirolimus Mar 06, 2012
Tacrolimus, CAS number 104987-11-3, was the second macrolide immunosuppressant discovered, second only to discovery of rapamycin (sirolimus) on Rapa Nui (Easter Island) in 1975. Discovered in 1984, tacrolimus, also known as FK-506 or Fujimycin, is an immunosuppressant drug, often given to organ transplant recipients. Tacrolimus is effective in helping to prevent transplant patients from experiencing[…]
Immunosuppressive Drugs for Transplant – Treatments, Side Effects, and Future Research & Development
Drug Research & Development API, Immunological Agent, Immunosuppressant Tags: 159351-69-6191732-72-6EverolimusFingolimod HydrochlorideImmunosuppressantLenalidomideMethotrexateSirolimus Mar 15, 2011
For organ transplant patients, the normally protective immune response can threaten the longevity and function of the transplanted organ. Currently, organ transplant patients must take immunosuppressive or anti-rejection medication to prevent the immune system from fighting against the new, transplanted organ. Often a choice is made between the certain damage of a steroid drug, and[…]
